search
Back to results

Basic Hemodynamic Monitoring Reliability During Percutaneous Nephrolithotomy.

Primary Purpose

Renal Stone

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
spinal anesthesia monitoring
Sponsored by
Mansoura University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Renal Stone focused on measuring Cardiac output, Hemodynamic, Monitoring, Percutaneous.

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients scheduled for percutaneous nephrolithotomy endoscopic operation
  2. ASA I-III.
  3. Both sexes,
  4. Age 18 - 70 years.
  5. PCNL operation time ≥120 minutes.

Exclusion Criteria:

  1. Patient refusal.
  2. PCNL operation time <120 minutes.
  3. Hypersensitivity to amide local anesthetics.
  4. General contraindications to spinal anesthesia, coagulopathy.
  5. Cardiac, hepatic, renal or respiratory failure.
  6. Difficult communication.

Sites / Locations

  • Mansoura University, Faculty of Medicine

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

cop variables

Arm Description

non invasive cop vsriables correlation to basic monitoring variables during prone position spinal anesthesia intervention pcnl operation at basic ,1hour and 2hours .

Outcomes

Primary Outcome Measures

Stroke volume index (SVI)
continuous stroke volume index (stroke volume divided by the body weight) during prone position spinal anesthesia

Secondary Outcome Measures

Full Information

First Posted
January 29, 2019
Last Updated
April 26, 2019
Sponsor
Mansoura University
search

1. Study Identification

Unique Protocol Identification Number
NCT03828175
Brief Title
Basic Hemodynamic Monitoring Reliability During Percutaneous Nephrolithotomy.
Official Title
Basic Hemodynamics in Correlation With Noninvasive Cardiac Output: A Diagnostic Reliability Issue During Percutaneous Nephrolithotomy Bleeding Under Spinal Anesthesia
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
April 1, 2019 (Actual)
Study Completion Date
April 5, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This prospective pre and post-quasi-descriptive single group interventional study will be done at urology and nephrology center -Mansoura University during the year 2019, for a 3-month duration, starting 1-2-2019 till 1-4-2019 after approval of IRB (Institutional Review Board) code no R/18.03.103 on 5/5/2018, Mansoura Faculty of Medicine. correlating Basic hemodynamics with noninvasive cardiac output for diagnostic reliability during percutaneous nephrolithotomy hidden bleeding under spinal anesthesia
Detailed Description
Hypothesis: On the concept of patient safety, using basic noninvasive monitoring tools (Blood pressure, HR, pulse oximetry O2 Saturation) are late and deceiving and non-reliable hemodynamic measuring tools in diagnosing the progression of the silent hidden bleeding during percutaneous nephrolithotomy surgery (PCNL) operations and necessitate adding noninvasive COP (bioimpedance based) monitor for minute to minute detection of the hemodynamic changes during (PCNL) surgery (necessitates high level spinal anesthesia and prolonged prone position with its hemodynamic burden, carries high risk of inaccessible uncontrollable bleeding). The aim of the work: Targeting more intraoperative patient safety by determination of the credibility of basic hemodynamic monitors in reflecting the real cardiopulmonary functions during PCNL operation (high risk is hidden bleeding) under prone position spinal anesthesia. Achieved by using correlation between intraoperative noninvasive thoracic bioimpedance [COP -oxygenation] monitor and the usually used basic intraoperative [hemodynamic-oxygenation] monitoring systems; two outcome categories will be correlated; a)-Circulatory category: thoracic bioimpedance based COP hemodynamic parameters including (cardiac output COP-stroke volume SV -stroke index SI- cardiac index CI-cardiac performance index CPI-stroke volume variability SVV, systemic vascular resistance SVR, systemic vascular resistance index SVRI) correlation with the usual basic hemodynamic monitoring dependent parameters noninvasive blood pressure NIBP (systolic SBP and mean MAP) and the heart rate HR. b)- Oxygenation category: (Oxygen delivery (Do2), Oxygen delivery index (Do2I), correlation with the basic monitor pulse oximeter oxygen saturation (Sao2). Correlation will be done at 3 times first basal (just after prone position adjustment and before PCNL puncture, after 60 min then after 120 minutes of prone position adjustment. Patient & Methods: This prospective pre and post-quasi-descriptive single group interventional study will be done at urology and nephrology center -Mansoura University during the year 2019, for a 3-month duration, starting 1-2-2019 till 1-4-2019 after approval of IRB (Institutional Review Board) code no R/18.03.103 on 5/5/2018, Mansoura Faculty of Medicine. Sample size calculation Sample size was calculated using Power Analysis and Sample Size software program (PASS) version 15.0.5 for Windows (2017) using results obtained by a pilot study conducted on 5 patients at Mansoura urology and nephrology center (January-2019) with the difference in reliability (as measured by Cronbach's alpha) between mean non-invasive blood pressure (MAP) and stroke volume index (SVI) as the primary outcome. We choose the SVI over other monitoring tools as cardiac output or the cardiac index due to its relatively more available measurement tools. A sample size of 32 patients is needed to achieve 90% power and detect the difference between the Cronbach's alpha of the MAP (considered to be the null hypothesis) of 0.974 and the Cronbach's alpha for the SVI of 0.988 using a two-sided F-test with a significance level of 0.05. The expected number of drop-outs is 8, so a total of 40 patients will be enrolled into the study. Preparation: After patient examination and consultation about any comorbidities. Consent will be taken after explanation of the anesthetic procedures, 1000 ml Ringers solution during 30 minutes before anesthesia the morning of the procedure. Intraoperative management: After attaching all standard monitors (ECG, NIBP, pulse oximeter) and the COP bio-impedance monitor recording basal data (COP, CI, SV, CPI, CaO2, Do2, DO2I, SVR, SVV. During sitting position intrathecal anesthesia was conducted in the sitting position under complete aseptic condition using heavy bupivacaine 15mg (3ml) plus 10micrograms dexamedatomedine using 25G needle after 2 ml Lidocaine skin infiltration. lithotomy position till anesthesia level documented T4-5 and fixed and lower urinary tract endoscopy then shifting the patient to prone position and after adjustment of the prone position precautions 2 bellows one under the chest and one under the pelvis with pliable free moving abdomen jell ring under the patient head knees and in front of heels, then the basal data recording and after that data recording every 10 minutes till end of the operative procedure,With basal& postoperative HB detection. Episodes of perioperative: Hypotension is defined as mean arterial blood pressure (MBP) less than 65 mmHg, will be managed by using bolus doses of ephedrine 6 mg, fluids and blood transfusion according to patients HB level with blood transfusion cut point of 8mg/dl. Bradycardia is defined as HR less than 60 b/m. will be managed by atropine 0.5 mg bolus. Desaturation is defined as SaO2< 90% will be managed by stop surgery, increase O2 flow via the oxygen face mask from 5 to 10 liters/minute, chest auscultation and verbal patient examination with shift to lithotomy position if desaturation persist and keep all tools and drugs ready for intubation and mechanical ventilation if needed. Nausea will be managed by treatment of hypotension as a common cause and propofol 20 mg. vomiting will be treated by dexamethasone 0.1mg/Kg with metoclopramide 0.1mg/Kg. Intraoperative pain will be managed by fentanyl 0.5 mcg/kg, IV infusion of paracetamol 10mg/kg, propofol 50 mg increments, or general anesthesia using ETT and inhalational maintenance if there is still more than 15 min expected time to end the surgical procedure by shifting to lithotomy position and then General anesthesia induction with endotracheal intubation with mechanical ventilation then continue surgery and the case excluded from the study and replaced as a dropout case. Primary outcome: Stroke volume index (SVI) Secondary outcome: Hemoglobin (HB) (basal prior surgery &Postoperative), cardiac output (COP)- Stroke volume (SV)- Cardiac performance index (CPI)-systemic vascular resistance (SVR) - systemic vascular resistance index (SVRI) - stroke volume variability (SVV)- Oxygen delivery DOI-cardiac Index-Oxygen delivery (DO2)- Oxygen delivery index (DO2I). Noninvasive Intraoperative hemodynamic (systolic blood pressure (SBP), mean blood pressure (MAP), heart rate (HR) and O2 saturation (SaO2). All mentioned variables will be recorded basal and every 10 minutes till end of surgery. Statistical analysis IBM's SPSS statistics (Statistical Package for the Social Sciences) for Windows (version 25) will be used for statistical analysis of the collected data. Shapiro-Wilk test will be used to check the normality of the data distribution. Normally distributed continuous variables will be expressed as mean ± SD while categorical variables and the abnormally distributed continuous ones will be expressed as a median and inter-quartile range or number and percentage (as appropriate). Reliability analysis will be conducted using Cronbach's alpha test. Student t-test and Mann-Whitney will be used for normally and abnormally distributed continuous data respectively. Chi-square test will be used for categorical data using the crosstabs function. All tests will be conducted with 95% confidence interval. If needed, bivariate correlations will be assessed using Pearson's or Spearman's correlation coefficient depending on the nature of data. P (probability) value < 0.05 will be considered statistically significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Stone
Keywords
Cardiac output, Hemodynamic, Monitoring, Percutaneous.

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
cop variables
Arm Type
Other
Arm Description
non invasive cop vsriables correlation to basic monitoring variables during prone position spinal anesthesia intervention pcnl operation at basic ,1hour and 2hours .
Intervention Type
Procedure
Intervention Name(s)
spinal anesthesia monitoring
Intervention Description
After attaching all standard monitors (ECG, NIBP, pulse oximeter) and the COP bio-impedance monitor recording basal data (COP, CI, SV, CPI, Do2, DO2I, SVR, SVV. During sitting position intrathecal anesthesia was conducted in the sitting position under complete aseptic condition using heavy bupivacaine 15mg (3ml) plus 10 mic dexamedatomedine 25G needle after 2 ml Lidocaine skin infiltration. lithotomy position till anesthesia level documented T4 and fixed and lower urinary tract endoscopy then shifting the patient to prone position and after adjustment of the prone position precautions 2 bellows one under the chest and one under the pelvis with pliable free moving abdomen jell ring under the patient head knees and in front of heels, then the basal data recording and after that data recording every 10 minutes till end of the operative procedure. Blood sampling at basal, postoperative
Primary Outcome Measure Information:
Title
Stroke volume index (SVI)
Description
continuous stroke volume index (stroke volume divided by the body weight) during prone position spinal anesthesia
Time Frame
up to 120 minutes.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients scheduled for percutaneous nephrolithotomy endoscopic operation ASA I-III. Both sexes, Age 18 - 70 years. PCNL operation time ≥120 minutes. Exclusion Criteria: Patient refusal. PCNL operation time <120 minutes. Hypersensitivity to amide local anesthetics. General contraindications to spinal anesthesia, coagulopathy. Cardiac, hepatic, renal or respiratory failure. Difficult communication.
Facility Information:
Facility Name
Mansoura University, Faculty of Medicine
City
Mansourah
State/Province
DK
ZIP/Postal Code
050
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Basic Hemodynamic Monitoring Reliability During Percutaneous Nephrolithotomy.

We'll reach out to this number within 24 hrs